Docmode Health Technologies Ltd IPO: Issue Details, Open/Close Date | Research 360 by Motilal Oswal
Back arrow

Docmode Health



-7.45 (-4.99%)


Offer Price

₹ 6.71 Cr

Issue Size

₹ 1,26,400

Min Investment


Lot size

Time Line

  • 25
    Jan 2024
  • 29
    Jan 2024
  • 31
    Jan 2024
    Finalisation of Basis of Allotment
  • 01
    Feb 2024
    Initiation of Refunds
  • 01
    Feb 2024
    Transfer of Shares to Demat Account
  • 02
    Feb 2024
    Listing Date

Objects of the Offer

  • Brand building strategy that covers a judicial mix of print, video, digital and social media.

  • Develop and expand its publishing research articles and content development.

  • The Company will focus on healthcare services platform where the patients can interact with doctors for educating and support.

  • Create a practice tool like iNutrimon in every speciality.

Products & Services

  • The Company is engaged in the business of offering integrated learning solutions through online platform.


  • Technology driven, asset light & scalable business model.

  • Strong network effects resulting in growth business verticals.

  • Experience in the education business and professionally qualified human capital.

  • Diversified and integrated education products, services and content offerings.

  • Continue offering new course/lecture content.


  • The company is dependent on the relationships with healthcare professionals, and its business and financial results could be to an extent impacted if the company is not able to engage such healthcare professionals on a regular basis.

  • The company ability to retain the present number of learners and professionals serviced by it and attract new learners and professionals is dependent upon various factors including its reputation and the company ability to maintain a high level of service quality. Any failure by it to retain or attract learners and professionals may impact the business and its revenues.

  • The Company is yet to place orders for the purchase of IT infrastructure and operating system. Any delay in placing orders or procurement of such machinery may delay the schedule of implementation.

  • The business in which its operate is specifically regulated. The central and state governments may change the existing regulations or introduce a new regulatory framework in the future. The impact of such changes or new regulations on the business cannot be ascertained presently and may affect the company business adversely in the future.

  • The company`s success depends significantly on the company ability to continue to innovate and implement technological advances. If its are unable to keep pace with evolving technology and user preferences, the company business, results of operations and prospects may be adversely affected.

Company Promoters

Promoters Holding

Issue For IPO
Pre Holding


Post Holding


Top Promoters Holding


All values in Cr

Mar-2021 Mar-2022 Mar-2023 3-Yr trend
Revenue 7.10 (2.30%) 12.42 (74.90%) 32.88 (164.70%)
Gross Profit 7.10 (2.30%) 12.42 (74.90%) 32.88 (164.70%)
Net Income 7.10 (2.30%) 12.42 (74.90%) 32.88 (164.70%)
Assets 7.10 (2.30%) 12.42 (74.90%) 32.88 (164.70%)
Liabilities 7.10 (2.30%) 12.42 (74.90%) 32.88 (164.70%)

Book Running Managers

  • Fedex Securities Pvt Ltd

Registrar & Transfer Agent

Bigshare Services Pvt Ltd

Office No 56-2,
Pinnacle Busine.Park,
Mahakali Caves Road - Mumbai - 400093
Phone : 91-22-62638200 Fax: 91-22-63638299

Company Contact Information

201 Kalpataru Plaza Rambaug -,
off Chincholi Bunder Rd Malad,
Mumbai - 400064
Phone : 99209 23338 Email :

Offer Related Information

Initial public issue* of 8,49,600 equity shares of face value of Rs. 10/- each ("Equity Shares") of Docmode Health Technologies Limited ("The Company" or the "Issuer") for cash at a price of Rs. 79/- per equity share (the "Issue Price"), (including a premium of Rs. 69/- per equity share), aggregating Rs. 6.71 crores ("The Issue"), of which 43,200 equity shares of face value of Rs. 10/- for cash at a price of Rs. 79/- each aggregating Rs. 0.34 crores will be reserved for subscription by market... More

Take your research to the next level.
Login now to unlock Exclusive Features!

Take your research to the next level.
Login now to unlock Exclusive Features!

Download Our App On: